Sotac Pharmaceuticals Ltd

Sotac Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sotac Pharmaceuticals Ltd

₹ 136 -4.88%
26 Sep - close price
Company website NSE - SME: SOTAC
About

Incorporated in 2015, Co. is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis[1]

Key Points

Business Verticals
A) Manufacturing of Non-Beta-Lactam Medicines and Formulations [1]
It manufactures Non-Beta-Lactam (general) tablets, Non-Beta-Lactam (general) capsules, oral liquid, dry syrup, and external preparations such as Ointment, Lotion, and cream and caters to 162 corporate clients on a loan license and/or contract manufacturing basis

Website NSE - ST
  • Market Cap ₹ 150 Cr.
  • Current Price ₹ 136
  • High / Low ₹ 203 / 87.1
  • Stock P/E 25.1
  • Book Value ₹ 43.7
  • Dividend Yield 0.00 %
  • ROCE 19.3 %
  • ROE 16.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 27.2%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 84.9 to 120 days.
  • Working capital days have increased from 71.6 days to 161 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
15.05 30.75 14.06 13.18 18.91 14.20 17.68 16.31 13.01
12.13 25.68 12.96 10.80 16.65 11.52 14.75 14.00 10.90
Operating Profit 2.92 5.07 1.10 2.38 2.26 2.68 2.93 2.31 2.11
OPM % 19.40% 16.49% 7.82% 18.06% 11.95% 18.87% 16.57% 14.16% 16.22%
0.07 0.11 0.00 0.13 0.23 0.29 0.04 0.53 0.43
Interest 0.17 0.42 0.13 0.31 0.34 0.19 0.23 0.25 0.26
Depreciation 0.34 0.74 0.43 0.45 0.46 0.63 0.68 0.73 0.60
Profit before tax 2.48 4.02 0.54 1.75 1.69 2.15 2.06 1.86 1.68
Tax % 25.40% 23.13% 3.70% 29.14% 28.40% 22.33% 27.18% 25.81% 25.00%
1.86 3.09 0.51 1.23 1.21 1.67 1.49 1.38 1.25
EPS in Rs 8.09 13.43 0.63 1.53 1.10 1.51 1.35 1.25 1.13
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
43.44 73.15 57.98 67.11 61.20
40.58 65.13 49.73 57.15 51.17
Operating Profit 2.86 8.02 8.25 9.96 10.03
OPM % 6.58% 10.96% 14.23% 14.84% 16.39%
0.35 -1.63 0.24 1.32 1.29
Interest 0.61 0.58 0.90 1.01 0.93
Depreciation 1.11 1.13 1.63 2.51 2.64
Profit before tax 1.49 4.68 5.96 7.76 7.75
Tax % 0.00% 29.91% 24.66% 25.90%
1.48 3.30 4.50 5.75 5.79
EPS in Rs 6.43 14.35 5.59 5.20 5.24
Dividend Payout % 0.00% 13.94% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 16%
TTM: -20%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 57%
TTM: -1%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 9%
Return on Equity
10 Years: %
5 Years: %
3 Years: 27%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 2.30 2.30 8.05 11.05
Reserves 2.51 4.80 12.94 37.22
6.68 7.39 10.66 11.17
11.01 21.82 23.13 16.65
Total Liabilities 22.50 36.31 54.78 76.09
6.42 8.80 14.09 17.67
CWIP 0.00 0.00 0.04 0.05
Investments 0.00 0.00 4.00 11.50
16.08 27.51 36.65 46.87
Total Assets 22.50 36.31 54.78 76.09

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024
2.22 3.58 8.54 -19.79
-1.07 -3.28 -10.93 -12.53
-1.17 -0.30 11.97 23.36
Net Cash Flow -0.02 0.00 9.57 -8.96

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 52.68 62.57 72.40 119.71
Inventory Days 40.71 35.14 87.26 88.97
Days Payable 112.49 128.97 165.78 119.08
Cash Conversion Cycle -19.10 -31.25 -6.12 89.59
Working Capital Days 26.97 29.09 24.93 160.94
ROCE % 54.66% 29.74% 19.26%

Shareholding Pattern

Numbers in percentages

Apr 2023Sep 2023Mar 2024
72.85% 72.85% 72.85%
12.88% 8.51% 8.99%
14.27% 18.64% 18.16%
No. of Shareholders 784255245

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports